1. Home
  2. DFIN vs BHVN Comparison

DFIN vs BHVN Comparison

Compare DFIN & BHVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Donnelley Financial Solutions Inc.

DFIN

Donnelley Financial Solutions Inc.

HOLD

Current Price

$46.34

Market Cap

1.2B

ML Signal

HOLD

Logo Biohaven Ltd.

BHVN

Biohaven Ltd.

HOLD

Current Price

$11.20

Market Cap

1.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
DFIN
BHVN
Founded
1983
2013
Country
United States
United States
Employees
N/A
N/A
Industry
Other Consumer Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.2B
1.1B
IPO Year
N/A
2017

Fundamental Metrics

Financial Performance
Metric
DFIN
BHVN
Price
$46.34
$11.20
Analyst Decision
Strong Buy
Buy
Analyst Count
2
16
Target Price
$63.50
$29.79
AVG Volume (30 Days)
272.4K
3.1M
Earning Date
10-29-2025
11-10-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
1.12
N/A
Revenue
$750,800,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$4.20
$2,219.74
P/E Ratio
$40.84
N/A
Revenue Growth
N/A
N/A
52 Week Low
$37.80
$7.48
52 Week High
$69.93
$44.28

Technical Indicators

Market Signals
Indicator
DFIN
BHVN
Relative Strength Index (RSI) 47.77 53.84
Support Level $44.10 $10.69
Resistance Level $46.60 $11.80
Average True Range (ATR) 1.37 0.75
MACD 0.01 0.32
Stochastic Oscillator 41.10 82.92

Price Performance

Historical Comparison
DFIN
BHVN

About DFIN Donnelley Financial Solutions Inc.

Donnelley Financial Solutions Inc is a risk and compliance solutions company. The company provides regulatory filing and deal solutions via its software-as-a-service, technology-enabled services, and print and distribution solutions to public and private companies, mutual funds, and other regulated investment firms. The company operates in four segments: Capital Markets - Software Solutions, Capital Markets - Compliance and Communications Management, Investment Companies - Software Solutions and Investment Companies - Compliance and Communications Management. Its geographical segments are the United States( USA), Europe, Asia, Canada, and others, of which the USA accounts for the vast majority of its total revenue.

About BHVN Biohaven Ltd.

Biohaven Ltd is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of life-changing treatments in key therapeutic areas, including immunology, neuroscience, and oncology. Its product pipeline includes Glutamate, Myostatin, Ion channels, Inflammation & Immunology, and Oncology. The company's products target diseases such as neuromuscular and metabolic diseases, antibody-drug conjugates for cancer, obsessive-compulsive disorder, and others.

Share on Social Networks: